ACEVECTOR vs ENTERO: Stock Comparison
ENTERO HEALTHCARE SOLU L is the larger company by market capitalisation. ENTERO HEALTHCARE SOLU L shows faster revenue growth and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
ACEVECTOR leads 0; ENTERO leads 3 of 4
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | ACEVECTOR | ENTERO |
|---|---|---|
| Sector | — | Consumer Services |
| Industry | — | Pharmacy Retail |
Price
| Metric | ACEVECTOR | ENTERO |
|---|---|---|
| Live Price | ₹24.04 | ₹1,503.9 |
| Day Change | -3.61% | -5.12% |
| Volume | 51.94 L | 1.65 L |
| 52-Week High | ₹33.27 | ₹1,920 |
| 52-Week Low | ₹23.37 | ₹944 |
| Distance from 52W High | -27.74% | -21.67% |
Valuation
| Metric | ACEVECTOR | ENTERO |
|---|---|---|
| Market Cap | ₹1,310 Cr | ₹6,558 Cr |
| P/E Ratio | — | 52.28x |
| P/B Ratio | — | 3.88x |
| EPS | — | ₹8.77 |
| Book Value | — | ₹402.67 |
| Dividend Yield | 0% | 0% |
Growth
| Metric | ACEVECTOR | ENTERO |
|---|---|---|
| Revenue Growth (TTM YoY) | 0% | 42.6% |
| EPS Growth (TTM YoY) | 0% | 9.1% |
| Qtr Sales Growth | — | 0% |
| Qtr Profit Growth | — | 0% |
Profitability & Leverage
| Metric | ACEVECTOR | ENTERO |
|---|---|---|
| ROE | — | 1.6% |
| ROCE | — | 2.01% |
| Net Margin | 0% | 1.75% |
| Operating Margin | — | 9.99% |
| Debt to Equity | — | 0.06x |
Shareholding
As of Sep 2026 • change vs previous quarter| Metric | ACEVECTOR | ENTERO |
|---|---|---|
| Promoter Holding | 29.19% | 14.4%▼ 0.01 pp |
| FII Holding | 18.96% | 4.37%▲ 0.34 pp |
| DII Holding | 14.68% | 15.48%▼ 1.14 pp |
| Public Holding | 16.39% | 27.75%▲ 0.82 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ACEVECTOR and ENTERO HEALTHCARE SOLU L.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.